Assenagon Asset Management S.A. Acadia Pharmaceuticals Inc Transaction History
Assenagon Asset Management S.A.
- $54.8 Billion
- Q1 2025
A detailed history of Assenagon Asset Management S.A. transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 3,663,145 shares of ACAD stock, worth $52.6 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
3,663,145Holding current value
$52.6 Million% of portfolio
0.11%Shares
7 transactions
Others Institutions Holding ACAD
# of Institutions
327Shares Held
166MCall Options Held
855KPut Options Held
350K-
Baker Bros. Advisors LP New York, NY42.9MShares$615 Million8.72% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.9MShares$200 Million0.0% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$173 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY8.71MShares$125 Million2.61% of portfolio
-
Morgan Stanley New York, NY7.3MShares$105 Million0.01% of portfolio
About ACADIA PHARMACEUTICALS INC
- Ticker ACAD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 161,843,008
- Market Cap $2.32B
- Description
- ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...